circSMAD2 inhibits the epithelial & ndash;mesenchymal transition by targeting miR-629 in hepatocellular carcinoma
Source: OncoTargets and Therapy - Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
More News: Cancer & Oncology | Carcinoma | Epithelial Cancer | Hepatocellular Carcinoma | Liver Cancer